6ZY9 image
Deposition Date 2020-07-30
Release Date 2020-11-25
Last Version Date 2024-05-01
Entry Detail
PDB ID:
6ZY9
Keywords:
Title:
Cryo-EM structure of MlaFEDB in complex with AMP-PNP
Biological Source:
Method Details:
Experimental Method:
Resolution:
3.30 Å
Aggregation State:
PARTICLE
Reconstruction Method:
SINGLE PARTICLE
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:YrbD protein
Chain IDs:A, B (auth: D), C (auth: I), D (auth: J), E (auth: K), F (auth: L)
Chain Length:183
Number of Molecules:6
Biological Source:Escherichia coli B185
Polymer Type:polypeptide(L)
Molecule:ABC transporter maintaining OM lipid asymmetry, cytoplasmic STAS component
Chain IDs:G (auth: B), H (auth: C)
Chain Length:105
Number of Molecules:2
Biological Source:Escherichia coli
Polymer Type:polypeptide(L)
Molecule:Uncharacterized protein
Chain IDs:K (auth: E), L (auth: H)
Chain Length:260
Number of Molecules:2
Biological Source:Escherichia coli 2.3916
Polymer Type:polypeptide(L)
Molecule:Toluene tolerance protein Ttg2A
Chain IDs:I (auth: F), J (auth: G)
Chain Length:269
Number of Molecules:2
Biological Source:Escherichia coli 909945-2
Primary Citation
Structural insights into outer membrane asymmetry maintenance in Gram-negative bacteria by MlaFEDB.
Nat.Struct.Mol.Biol. 28 81 91 (2021)
PMID: 33199922 DOI: 10.1038/s41594-020-00532-y

Abstact

The highly asymmetric outer membrane of Gram-negative bacteria functions in the defense against cytotoxic substances, such as antibiotics. The Mla pathway maintains outer membrane lipid asymmetry by transporting phospholipids between the inner and outer membranes. It comprises six Mla proteins, MlaFEDBCA, including the ABC transporter MlaFEDB, which functions via an unknown mechanism. Here we determine cryo-EM structures of Escherichia coli MlaFEDB in an apo state and bound to phospholipid, ADP or AMP-PNP to a resolution of 3.3-4.1 Å and establish a proteoliposome-based transport system that includes MlaFEDB, MlaC and MlaA-OmpF to monitor the transport direction of phospholipids. In vitro transport assays and in vivo membrane permeability assays combined with mutagenesis identify functional residues that not only recognize and transport phospholipids but also regulate the activity and structural stability of the MlaFEDB complex. Our results provide mechanistic insights into the Mla pathway, which could aid antimicrobial drug development.

Legend

Protein

Chemical

Disease

Primary Citation of related structures